NeuroVasc Technologies Overview
Update this profile
Latest Deal Type
NeuroVasc Technologies General Information Description
Developer of novel catheter-based technologies designed to treat neurovascular disease. The company has developed a comprehensive portfolio development strategy to bring differentiated tools to the INR community to facilitate broader treatment options for patients suffering from a stroke and other neurovascular diseases, enabling physicians to treat patients suffering an acute ischemic stroke.
NeuroVasc Technologies Timeline
Financing Round Captured Employee Count Estimated Employee Growth
Want to dig into this profile?
We’ll help you find what you need
NeuroVasc Technologies Valuation & Funding
Raised to Date
3. Secondary Transaction - Private
2. Early Stage VC (Series B)
1. Early Stage VC (Series A)
To view NeuroVasc Technologies’s complete valuation and funding history, request access »
NeuroVasc Technologies Signals
0.80%, 93rd %ile
219x, 100th %ile
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial